Palabras clave
Renal vasculitis
Cómo citar
1.
Ramírez F, Rojas W, Jaramillo D, Ochoa C, Toro C, Méndez-Patarroyo P, Coral P, Cantillo J, Ramírez G, Quintana G, Restrepo J, Rondón F, Aroca G, Gamarra AI. Renal vasculitis in Colombia. Rev. Colomb. Nefrol. [Internet]. 1 de enero de 2015 [citado 3 de julio de 2024];2(1):3-11. Disponible en: https://revistanefrologia.org/index.php/rcn/article/view/192
Resumen
A retrospective review of publications about primary vasculitis cases was performed from the Colombian medical literature, the clinical and pathological features are described.
The Renal vasculitis occurred in 33.9% of cases of primary vasculitis reviewed and was more frequent in women. The main clinical, hematological, immunological variables and nephropathology and immunosuppressive treatments used findings are described.
Citas
1. Sinico RA, Di Toma L, Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis.
Autoimmun Rev. 2013;12(4):477-82.
2. John R, Herzenberg AM. Vasculitis affecting the kidney. Semin Diagn Pathol. 2009;26(2):89-102.
3. ZEEK PM. Periarteritis nodosa; a critical review. Am J Clin Pathol. 1952;22(8):777-90.
4. Bloch DA, Michel BA, Hunder GG, McShane DJ, Arend WP, Calabrese LH, et al. The American College of Rheumatology
1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum. 1990;33(8):1068-73.
5. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187-92.
6. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11.
7. Nordborg C, Johansson H, Petursdottir V, Nordborg E. The epidemiology of biopsy-positive giant cell arteritis: special
reference to changes in the age of the population. Rheumatology (Oxford). 2003;42(4):549-52.
8. Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum. 2004;51(2):264-8.
9. Kobayashi S, Yano T, Matsumoto Y, Numano F, Nakajima N, Yasuda K, et al. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum. 2003;49(4):594-8.
10. Yanagawa H, Nakamura Y, Yashiro M, Oki I, Hirata S, Zhang T, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics. 2001;107(3):E33.
11. Jiao F, Yang L, Li Y, Qiao J, Guo X, Zhang T, et al. Epidemiologic and clinical characteristics of Kawasaki disease in
Shaanxi Province, China, 1993-1997. J Trop Pediatr. 2001;47(1):54-6.
12. Du ZD, Zhang T, Liang L, Meng X, Li T, Kawasaki T, et al. Epidemiologic picture of Kawasaki disease in Beijing from 1995 through 1999. Pediatr Infect Dis J. 2002;21(2):103-7.
13. Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's
granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture
estimate. Arthritis Rheum. 2004;51(1):92-9.
14. Ormerod AS, Cook MC. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern
New South Wales. Intern Med J. 2008;38(11):816-23.
15. Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford).
2009;48(12):1560-5.
16. Haugeberg G, Bie R, Bendvold A, Larsen AS, Johnsen V. Primary vasculitis in a Norwegian community hospital: a retrospective study. Clin Rheumatol. 1998;17(5):364-8.
17. Abstracts of the 70th Annual Meeting of the American College of Rheumatology and the 41st Annual Meeting of the Association of Rheumatology Health Professionals, November 10-15, 2006, Washington, DC, USA. Arthritis Rheum. 2006;54(9 Suppl):S36-836.
18. Andrews M, Edmunds M, Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980s--is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond. 1990;24(4):284-8.
19. Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom.
Arthritis Rheum. 2000;43(2):414-9.
20. Patarroyo PA, Restrepo JF, Rojas SA, Rondón F, Matteson EL, Iglesias-Gamarra A. Are classification criteria for vasculitis useful in clinical practice? Observations and lessons from Colombia. J Autoimmune Dis. 2009;6:1.
21. Kallenberg CG, Heeringa P, Stegeman CA. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated
vasculitides. Nat Clin Pract Rheumatol. 2006;2(12):661-70.
22. Ferrario F, Vanzati A, Pagni F. Pathology of ANCA-associated vasculitis. Clin Exp Nephrol. 2012.
23. Hedger N, Stevens J, Drey N, Walker S, Roderick P. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis
in Wessex, UK: a 10-year retrospective study. Nephrol Dial Transplant. 2000;15(10):1593-9.
24. Day CJ, Howie AJ, Nightingale P, Shabir S, Adu D, Savage CO, et al. Prediction of ESRD in pauciimmune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine. Am J Kidney Dis. 2010;55(2):250-
8.
25. Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, et al. Renal histology in ANCA-associated
vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002;61(1):80-9.
26. Neumann I, Regele H, Kain R, Birck R, Meisl FT. Glomerular immune deposits are associated with increased proteinuria
in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant. 2003;18(3):524-31.
27. Chen M, Kallenberg CG. ANCA-associated vasculitides-- dvances in pathogenesis and treatment. Nat Rev Rheumatol. 2010;6(11):653-64.
28. Kain R, Exner M, Brandes R, Ziebermayr R, Cunningham D, Alderson CA, et al. Molecular mimicry in pauci-immune
focal necrotizing glomerulonephritis. Nat Med. 2008;14(10):1088-96.
29. Noh JY, Yasuda S, Sato S, Matsumoto M, Kunii Y, Noguchi Y, et al. Clinical characteristics of myeloperoxidase antineutrophil ytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J Clin Endocrinol Metab. 2009;94(8):2806-11.
30. Chen M, Gao Y, Guo XH, Zhao MH. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Nat Rev Nephrol. 2012;8(8):476-83.
Autoimmun Rev. 2013;12(4):477-82.
2. John R, Herzenberg AM. Vasculitis affecting the kidney. Semin Diagn Pathol. 2009;26(2):89-102.
3. ZEEK PM. Periarteritis nodosa; a critical review. Am J Clin Pathol. 1952;22(8):777-90.
4. Bloch DA, Michel BA, Hunder GG, McShane DJ, Arend WP, Calabrese LH, et al. The American College of Rheumatology
1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum. 1990;33(8):1068-73.
5. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187-92.
6. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11.
7. Nordborg C, Johansson H, Petursdottir V, Nordborg E. The epidemiology of biopsy-positive giant cell arteritis: special
reference to changes in the age of the population. Rheumatology (Oxford). 2003;42(4):549-52.
8. Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum. 2004;51(2):264-8.
9. Kobayashi S, Yano T, Matsumoto Y, Numano F, Nakajima N, Yasuda K, et al. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum. 2003;49(4):594-8.
10. Yanagawa H, Nakamura Y, Yashiro M, Oki I, Hirata S, Zhang T, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics. 2001;107(3):E33.
11. Jiao F, Yang L, Li Y, Qiao J, Guo X, Zhang T, et al. Epidemiologic and clinical characteristics of Kawasaki disease in
Shaanxi Province, China, 1993-1997. J Trop Pediatr. 2001;47(1):54-6.
12. Du ZD, Zhang T, Liang L, Meng X, Li T, Kawasaki T, et al. Epidemiologic picture of Kawasaki disease in Beijing from 1995 through 1999. Pediatr Infect Dis J. 2002;21(2):103-7.
13. Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's
granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture
estimate. Arthritis Rheum. 2004;51(1):92-9.
14. Ormerod AS, Cook MC. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern
New South Wales. Intern Med J. 2008;38(11):816-23.
15. Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford).
2009;48(12):1560-5.
16. Haugeberg G, Bie R, Bendvold A, Larsen AS, Johnsen V. Primary vasculitis in a Norwegian community hospital: a retrospective study. Clin Rheumatol. 1998;17(5):364-8.
17. Abstracts of the 70th Annual Meeting of the American College of Rheumatology and the 41st Annual Meeting of the Association of Rheumatology Health Professionals, November 10-15, 2006, Washington, DC, USA. Arthritis Rheum. 2006;54(9 Suppl):S36-836.
18. Andrews M, Edmunds M, Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980s--is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond. 1990;24(4):284-8.
19. Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom.
Arthritis Rheum. 2000;43(2):414-9.
20. Patarroyo PA, Restrepo JF, Rojas SA, Rondón F, Matteson EL, Iglesias-Gamarra A. Are classification criteria for vasculitis useful in clinical practice? Observations and lessons from Colombia. J Autoimmune Dis. 2009;6:1.
21. Kallenberg CG, Heeringa P, Stegeman CA. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated
vasculitides. Nat Clin Pract Rheumatol. 2006;2(12):661-70.
22. Ferrario F, Vanzati A, Pagni F. Pathology of ANCA-associated vasculitis. Clin Exp Nephrol. 2012.
23. Hedger N, Stevens J, Drey N, Walker S, Roderick P. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis
in Wessex, UK: a 10-year retrospective study. Nephrol Dial Transplant. 2000;15(10):1593-9.
24. Day CJ, Howie AJ, Nightingale P, Shabir S, Adu D, Savage CO, et al. Prediction of ESRD in pauciimmune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine. Am J Kidney Dis. 2010;55(2):250-
8.
25. Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, et al. Renal histology in ANCA-associated
vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002;61(1):80-9.
26. Neumann I, Regele H, Kain R, Birck R, Meisl FT. Glomerular immune deposits are associated with increased proteinuria
in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant. 2003;18(3):524-31.
27. Chen M, Kallenberg CG. ANCA-associated vasculitides-- dvances in pathogenesis and treatment. Nat Rev Rheumatol. 2010;6(11):653-64.
28. Kain R, Exner M, Brandes R, Ziebermayr R, Cunningham D, Alderson CA, et al. Molecular mimicry in pauci-immune
focal necrotizing glomerulonephritis. Nat Med. 2008;14(10):1088-96.
29. Noh JY, Yasuda S, Sato S, Matsumoto M, Kunii Y, Noguchi Y, et al. Clinical characteristics of myeloperoxidase antineutrophil ytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J Clin Endocrinol Metab. 2009;94(8):2806-11.
30. Chen M, Gao Y, Guo XH, Zhao MH. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Nat Rev Nephrol. 2012;8(8):476-83.
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de Creative Commons Reconocimiento- NoComercial- SinObraDerivada 4.0 Internacional. que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.